The World Health Organisation says it has coordinated shipment of an experimental Ebola vaccine and drugs to treat a laboratory scientist in Hungary who caught the potentially deadly disease in an accident earlier this month.
The U.N. health agency said in an emailed statement on Friday that Hungarian officials asked for help last week after a scientist working in a normally secure laboratory had an "accidental exposure" to Ebola.
WHO said it helped get the scientist immunized with an experimental vaccine. It also helped send two unlicensed drugs.
WHO said the risk of Ebola spreading from the scientist is "negligible" and that the scientist was immediately isolated in a Budapest hospital. It noted the person didn't have any symptoms.
Ebola typically has a fatality rate of about 50 percent.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app